| 000 | 01629 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515160922.0 | ||
| 264 | 0 | _c20090505 | |
| 008 | 200905s 0 0 eng d | ||
| 022 | _a1365-2893 | ||
| 024 | 7 |
_a10.1111/j.1365-2893.2009.01080.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGrebely, J | |
| 245 | 0 | 0 |
_aLow uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents. _h[electronic resource] |
| 260 |
_bJournal of viral hepatitis _cMay 2009 |
||
| 300 |
_a352-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aCanada _xepidemiology |
| 650 | 0 | 4 | _aCities |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 |
_aDrug Prescriptions _xstatistics & numerical data |
| 650 | 0 | 4 |
_aDrug Therapy _xstatistics & numerical data |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xepidemiology |
| 650 | 0 | 4 |
_aHepatitis C _xdrug therapy |
| 650 | 0 | 4 |
_aHepatitis C Antibodies _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSeroepidemiologic Studies |
| 650 | 0 | 4 | _aUrban Population |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aRaffa, J D | |
| 700 | 1 | _aLai, C | |
| 700 | 1 | _aKrajden, M | |
| 700 | 1 | _aKerr, T | |
| 700 | 1 | _aFischer, B | |
| 700 | 1 | _aTyndall, M W | |
| 773 | 0 |
_tJournal of viral hepatitis _gvol. 16 _gno. 5 _gp. 352-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2893.2009.01080.x _zAvailable from publisher's website |
| 999 |
_c18668982 _d18668982 |
||